PharmGKB: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:PharmGKB}} | |||
== Overview == | == Overview == | ||
[[File:PharmGKB_logo.png|thumb|right|PharmGKB logo]] | |||
'''PharmGKB''' (Pharmacogenomics Knowledgebase) is a comprehensive online resource that collects, curates, and disseminates information about the impact of human genetic variation on drug responses. It is a critical tool for researchers, clinicians, and educators in the field of [[pharmacogenomics]]. | |||
PharmGKB | == History == | ||
PharmGKB was established to address the growing need for a centralized repository of pharmacogenomic data. It was developed by a team of researchers and is maintained by the Stanford University School of Medicine. The database has evolved over the years to include a wide range of data types, including [[genotype]] and [[phenotype]] information, [[drug]] pathways, and [[clinical guideline]]s. | |||
== | == Features == | ||
PharmGKB provides several key features that make it an invaluable resource: | |||
* '''Genotype-Phenotype Relationships''': The database includes detailed information on how specific genetic variants affect drug response, including [[adverse drug reaction]]s and [[therapeutic efficacy]]. | |||
* | * '''Drug Pathways''': PharmGKB offers curated pathways that illustrate the interactions between drugs and the biological systems they affect. These pathways help users understand the mechanisms of drug action and the role of genetic variation. | ||
* | * '''Clinical Annotations''': The database provides clinical annotations that summarize the evidence linking genetic variants to drug response, including recommendations for [[pharmacogenomic testing]]. | ||
* | * '''Guidelines''': PharmGKB includes guidelines from organizations such as the [[Clinical Pharmacogenetics Implementation Consortium]] (CPIC) and the [[Dutch Pharmacogenetics Working Group]] (DPWG), which offer recommendations for adjusting drug therapy based on genetic information. | ||
== | == Data Access and Use == | ||
PharmGKB is freely accessible to the public and can be used by researchers, clinicians, and educators. Users can search for information by [[gene]], [[drug]], or [[disease]], and can download data for further analysis. The database is regularly updated to include the latest research findings in the field of pharmacogenomics. | |||
PharmGKB | == Impact on Personalized Medicine == | ||
PharmGKB plays a crucial role in the advancement of [[personalized medicine]]. By providing a centralized resource for pharmacogenomic data, it enables healthcare providers to tailor drug therapy to individual patients based on their genetic makeup. This approach can improve drug efficacy, reduce adverse drug reactions, and optimize treatment outcomes. | |||
== Related pages == | |||
* [[Pharmacogenomics]] | * [[Pharmacogenomics]] | ||
* [[ | * [[Personalized medicine]] | ||
* [[ | * [[Genetic testing]] | ||
* [[ | * [[Clinical Pharmacogenetics Implementation Consortium]] | ||
[[Category:Pharmacogenomics]] | [[Category:Pharmacogenomics]] | ||
[[Category:Medical databases]] | |||
[[Category:Medical | |||
Latest revision as of 03:36, 13 February 2025
Overview[edit]
PharmGKB (Pharmacogenomics Knowledgebase) is a comprehensive online resource that collects, curates, and disseminates information about the impact of human genetic variation on drug responses. It is a critical tool for researchers, clinicians, and educators in the field of pharmacogenomics.
History[edit]
PharmGKB was established to address the growing need for a centralized repository of pharmacogenomic data. It was developed by a team of researchers and is maintained by the Stanford University School of Medicine. The database has evolved over the years to include a wide range of data types, including genotype and phenotype information, drug pathways, and clinical guidelines.
Features[edit]
PharmGKB provides several key features that make it an invaluable resource:
- Genotype-Phenotype Relationships: The database includes detailed information on how specific genetic variants affect drug response, including adverse drug reactions and therapeutic efficacy.
- Drug Pathways: PharmGKB offers curated pathways that illustrate the interactions between drugs and the biological systems they affect. These pathways help users understand the mechanisms of drug action and the role of genetic variation.
- Clinical Annotations: The database provides clinical annotations that summarize the evidence linking genetic variants to drug response, including recommendations for pharmacogenomic testing.
- Guidelines: PharmGKB includes guidelines from organizations such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG), which offer recommendations for adjusting drug therapy based on genetic information.
Data Access and Use[edit]
PharmGKB is freely accessible to the public and can be used by researchers, clinicians, and educators. Users can search for information by gene, drug, or disease, and can download data for further analysis. The database is regularly updated to include the latest research findings in the field of pharmacogenomics.
Impact on Personalized Medicine[edit]
PharmGKB plays a crucial role in the advancement of personalized medicine. By providing a centralized resource for pharmacogenomic data, it enables healthcare providers to tailor drug therapy to individual patients based on their genetic makeup. This approach can improve drug efficacy, reduce adverse drug reactions, and optimize treatment outcomes.
